2003•The Internet Journal of Internal MedicineRequires access

Cut-Off Fasting Plasma Glucose Level To Determine Impaired Glucose Metabolism In Obesity

Author information unavailable

Open publisher page 0 citations

Abstract

Objective: Our aim was to find out which fasting glucose level should be the cut-off point for impaired glucose metabolism in obese patients. Subjects: 257 patients (195 females, 62 males) whose body mass indexes (BMI) were above 30kg/m² participated in this study. After all cases had underwent a 75gr oral glucose tolerance test (OGTT) the patients were divided into four groups according to their fasting plasma glucose values ( group 1:80-89mg/dl (4.4-4.9mmol/l), group 2:90-99mg/dl (5.0-5.5mmol/l), group 3:100-109mg/dl (5.6-6.0mmol/l), group 4 :110-125mg/dl (6.1-6.9mmol/l) ). According to OGTT results we defined patients as cases who were normal, who had impaired fasting glucose, and who had impaired glucose metabolism (diabetes mellitus and impaired glucose tolerance). Results: No difference was found between age, gender, BMI, systolic and diastolic blood pressure, and lipid profiles of the groups. The number of patients who were diagnosed as impaired glucose metabolism increased apparently in the third group (%50.7) (p<0.05). Mean fasting plasma glucose level of the third group was 104,16±2,73mg/dl (5.78±0,15mmol/l). Although there was no statistically difference between the groups, mean homeostasis model assessment (HOMA) values were above 4 in the third and fourth groups, in the patients who had impaired fasting glucose and impaired glucose metabolism. Conclusion: We think that it is necessary to apply a OGTT to obese patients whose fasting plasma glucose levels are above 104 mg/dl in order to reduce the mortality and morbidity of the cardiovascular diseases.

About this research paper

What this paper is about

Objective: Our aim was to find out which fasting glucose level should be the cut-off point for impaired glucose metabolism in obese patients. Subjects: 257 patients (195 females, 62 males) whose body mass indexes (BMI) were above 30kg/m² participated in this study. After all cases had underwent a 75gr oral glucose tolerance test (OGTT) the patients were divided into four groups according to their fasting plasma glucose values ( group 1:80-89mg/dl (4.4-4.9mmol/l), group 2:90-99mg/dl (5.0-5.5mmol/l), group 3:100-109mg/dl (5.6-6.0mmol/l), group 4 :110-125mg/dl (6.1-6.9mmol/l) ). According to OGTT results we defined patients as cases who were normal, who had impaired fasting glucose, and who had impaired glucose metabolism (diabetes mellitus and impaired glucose tolerance). Results: No difference was found between age, gender, BMI, systolic and diastolic blood pressure, and lipid profiles of the groups. The number of patients who were diagnosed as impaired glucose metabolism increased apparently in the third group (%50.7) (p<0.05). Mean fasting plasma glucose level of the third group was 104,16±2,73mg/dl (5.78±0,15mmol/l). Although there was no statistically difference between the groups, mean homeostasis model assessment (HOMA) values were above 4 in the third and fourth groups, in the patients who had impaired fasting glucose and impaired glucose metabolism. Conclusion: We think that it is necessary to apply a OGTT to obese patients whose fasting plasma glucose levels are above 104 mg/dl in order to reduce the mortality and morbidity of the cardiovascular diseases.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: Our aim was to find out which fasting glucose level should be the cut-off point for impaired glucose metabolism in obese patients. Subjects: 257 patients (195 females, 62 males) whose body mass indexes (BMI) were above 30kg/m² participated in this study. After all cases had underwent a 75gr oral glucose tolerance test (OGTT) the patients were divided into four groups according to their fasting plasma glucose values ( group 1:80-89mg/dl (4.4-4.9mmol/l), group 2:90-99mg/dl (5.0-5.5mmol/l), group 3:100-109mg/dl (5.6-6.0mmol/l), group 4 :110-125mg/dl (6.1-6.9mmol/l) ). According to OGTT results we defined patients as cases who were normal, who had impaired fasting glucose, and who had impaired glucose metabolism (diabetes mellitus and impaired glucose tolerance). Results: No difference was found between age, gender, BMI, systolic and diastolic blood pressure, and lipid profiles of the groups. The number of patients who were diagnosed as impaired glucose metabolism increased apparently in the third group (%50.7) (p<0.05). Mean fasting plasma glucose level of the third group was 104,16±2,73mg/dl (5.78±0,15mmol/l). Although there was no statistically difference between the groups, mean homeostasis model assessment (HOMA) values were above 4 in the third and fourth groups, in the patients who had impaired fasting glucose and impaired glucose metabolism. Conclusion: We think that it is necessary to apply a OGTT to obese patients whose fasting plasma glucose levels are above 104 mg/dl in order to reduce the mortality and morbidity of the cardiovascular diseases.

Key concepts: Internal medicine, Impaired fasting glucose, Medicine, Endocrinology, Impaired glucose tolerance, Carbohydrate metabolism, Plasma glucose, Glucose Metabolism Disorder

Related papers

Back to paper searchBrowse research topicsOriginal source
Cut-Off Fasting Plasma Glucose Level To Determine Impaired Glucose Metabolism In Obesity — Research Paper | ScholarLens